Torray Investment Partners LLC Grows Stock Holdings in Ryan Specialty Holdings, Inc. (NYSE:RYAN)

Torray Investment Partners LLC increased its stake in Ryan Specialty Holdings, Inc. (NYSE:RYAN) by 9.3% during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 39,599 shares of the company’s stock after purchasing an additional 3,374 shares during the quarter. Torray Investment Partners LLC’s holdings in Ryan Specialty were worth $2,293,000 at the end of the most recent quarter.

Other large investors have also added to or reduced their stakes in the company. GAMMA Investing LLC lifted its stake in shares of Ryan Specialty by 96.4% in the 2nd quarter. GAMMA Investing LLC now owns 605 shares of the company’s stock worth $35,000 after purchasing an additional 297 shares during the period. Crewe Advisors LLC bought a new stake in shares of Ryan Specialty during the 2nd quarter valued at $39,000. Intelligent Financial Strategies purchased a new stake in shares of Ryan Specialty in the 1st quarter worth $44,000. Benjamin F. Edwards & Company Inc. purchased a new stake in shares of Ryan Specialty in the 1st quarter worth $45,000. Finally, Rothschild Investment LLC bought a new position in Ryan Specialty in the 2nd quarter worth $87,000. Institutional investors own 84.82% of the company’s stock.

Analyst Ratings Changes

A number of brokerages have commented on RYAN. The Goldman Sachs Group upped their price target on Ryan Specialty from $58.00 to $64.00 and gave the stock a “neutral” rating in a research report on Monday, August 5th. Wells Fargo & Company increased their target price on shares of Ryan Specialty from $60.00 to $63.00 and gave the stock an “equal weight” rating in a report on Friday, August 2nd. JPMorgan Chase & Co. lifted their price target on shares of Ryan Specialty from $54.00 to $56.00 and gave the company an “underweight” rating in a report on Friday, August 2nd. Bank of America began coverage on shares of Ryan Specialty in a research note on Wednesday, May 22nd. They issued a “buy” rating and a $67.00 price objective for the company. Finally, Barclays assumed coverage on shares of Ryan Specialty in a research note on Wednesday. They set an “overweight” rating and a $76.00 target price on the stock. One investment analyst has rated the stock with a sell rating, six have assigned a hold rating and four have assigned a buy rating to the company. According to MarketBeat, the stock presently has a consensus rating of “Hold” and an average price target of $63.40.

Insider Activity

In related news, EVP Jeremiah Rawlins Bickham sold 26,233 shares of the firm’s stock in a transaction dated Wednesday, August 14th. The shares were sold at an average price of $65.18, for a total value of $1,709,866.94. Following the transaction, the executive vice president now owns 24,845 shares of the company’s stock, valued at approximately $1,619,397.10. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. In other Ryan Specialty news, EVP Jeremiah Rawlins Bickham sold 26,233 shares of the company’s stock in a transaction on Wednesday, August 14th. The stock was sold at an average price of $65.18, for a total value of $1,709,866.94. Following the completion of the sale, the executive vice president now directly owns 24,845 shares in the company, valued at approximately $1,619,397.10. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, Director Nicholas Dominic Cortezi sold 5,375 shares of the stock in a transaction on Wednesday, August 28th. The stock was sold at an average price of $64.73, for a total value of $347,923.75. Following the transaction, the director now directly owns 2,685 shares in the company, valued at approximately $173,800.05. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 2,107,136 shares of company stock valued at $131,860,032. 11.10% of the stock is currently owned by insiders.

Ryan Specialty Price Performance

Shares of Ryan Specialty stock traded down $0.74 during trading hours on Friday, reaching $63.63. The company’s stock had a trading volume of 457,232 shares, compared to its average volume of 883,665. The company has a debt-to-equity ratio of 1.81, a current ratio of 1.09 and a quick ratio of 1.09. Ryan Specialty Holdings, Inc. has a one year low of $41.49 and a one year high of $69.03. The firm has a 50 day moving average price of $61.76 and a 200-day moving average price of $56.22. The stock has a market cap of $16.57 billion, a P/E ratio of 120.06, a P/E/G ratio of 1.53 and a beta of 0.62.

Ryan Specialty (NYSE:RYAN) last issued its quarterly earnings data on Thursday, August 1st. The company reported $0.58 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.56 by $0.02. The business had revenue of $695.40 million for the quarter, compared to the consensus estimate of $695.56 million. Ryan Specialty had a return on equity of 48.08% and a net margin of 10.21%. The company’s quarterly revenue was up 18.9% compared to the same quarter last year. During the same period in the prior year, the business posted $0.45 earnings per share. On average, analysts predict that Ryan Specialty Holdings, Inc. will post 1.81 EPS for the current year.

Ryan Specialty Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Tuesday, August 27th. Shareholders of record on Tuesday, August 13th were given a dividend of $0.11 per share. The ex-dividend date of this dividend was Tuesday, August 13th. This represents a $0.44 annualized dividend and a dividend yield of 0.69%. Ryan Specialty’s dividend payout ratio (DPR) is presently 83.02%.

Ryan Specialty Profile

Ryan Specialty Holdings, Inc operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, Europe, and Singapore. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.